$ FY18 Into FY19

Wanna talk cash?

Endless dilution, compounded by endless anxiety over endless dilution = vicious cycle.

Telling oneself, "better to own something of everything, than everything of nothing," etc...

Well, not here mate! RGS is on the runway, albeit a long runway.

"...the company has sufficient funding to support its R&D, clinical trials and operating activities for FY '18 and FY '19."

Not enough for ya? How 'bout this:

"Further licensing opportunities will provide additional funding for incremental activities."

And all that's from page 1!

OV